SQI Diagnostics Inc. | Cash Flow

Fiscal year is October-September. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
6,207.00
5,460.00
6,097.00
5,039.00
5,929.00
7,437
Depreciation, Depletion & Amortization
669.00
652.00
551.00
536.00
499.00
460
Other Funds
499.00
308.00
331.00
338.00
511.00
669
Funds from Operations
5,039.00
4,500.00
5,215.00
4,165.00
4,919.00
6,308
Changes in Working Capital
483.00
35.00
24.00
562.00
55.00
344
Net Operating Cash Flow
5,522.00
4,535.00
5,239.00
4,727.00
4,864.00
6,652
Capital Expenditures
429.00
212.00
316.00
277.00
230.00
Sale of Fixed Assets & Businesses
-
2.00
24.00
-
19.00
Net Investing Cash Flow
429.00
210.00
292.00
277.00
211.00
Issuance/Reduction of Debt, Net
-
-
3,011.00
-
-
Net Financing Cash Flow
3,548.00
5,065.00
5,648.00
6,073.00
3,620.00
Net Change in Cash
2,403.00
320.00
117.00
1,069.00
1,455.00
Free Cash Flow
5,758.00
4,561.00
5,356.00
4,822.00
4,961.00
Change in Capital Stock
3,548.00
5,065.00
2,637.00
6,073.00
3,620.00

About SQI Diagnostics

View Profile
Address
36 Meteor Drive
Toronto Ontario M9W 1A4
Canada
Employees -
Website http://www.sqidiagnostics.com
Updated 07/08/2019
SQI Diagnostics, Inc. is a life sciences and diagnostics company. It develops multiplexed tests and automated systems for customers who need to measure a variety of biomarkers in blood or other common sample types and commercialize proprietary technologies and products for microarray diagnostics. It offers solutions to pharmaceutical and biotechnology drug development, human diagnostic testing, and animal health diagnostic tests.